SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical
DECODE GENETICS-*DCGN
An SI Board Since July 2000
Posts SubjectMarks Bans Symbol
313 31 0 DCGN
Emcee:  Secret_Agent_Man Type:  Unmoderated
Introduction Market Data Compact
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
ReplyMessage PreviewFromRecsPosted
263Thanks! I did get a chance to listen to the replay. There had been some musingkenhott-10/9/2006
262I'm not going to beat this horse too much more, but just re-iterate what I ptommysdad-10/9/2006
261Those are strange comments, IMO. DCGN is a <i>business</i>. How canDewDiligence_on_SI-10/8/2006
260Lame? Lordy no. I think it is precisely how many management teams (not only attommysdad-10/8/2006
259Should I be ashamed that my comment was necessarily and sufficiently lame it brokeokalani'nui-10/7/2006
258I think that's biotech thinking, by which I mean not thinking long-term ;o).tommysdad-10/7/2006
257Both intervene in the 5-leukotrine pathway, though x051 attacks a novel target akeokalani'nui-10/6/2006
256It’s reasonable to assume that 051 is now the lead drug, IMO. Why would they neeDewDiligence_on_SI-10/6/2006
2551. Old mfg process used for P2. 2. Old mfg process could not scale-up for larkeokalani'nui-10/6/2006
254Nevermind.kenhott-10/6/2006
253Did anyone listen to the CC? I missed it.kenhott-10/6/2006
252At least it wasn't 6.35 on a Friday... :-)nigel bates-10/6/2006
251<i>This could be worse than it looks.</i> PR’s that come out at 6:3DewDiligence_on_SI-10/5/2006
250I wonder if the release rate of P3 material is different than in the P2 and if akeokalani'nui-10/5/2006
249deCODE Suspends Phase III Trial of DG031 to Improve Tablet Manufacturing Thursdakeokalani'nui-10/5/2006
248Error 2. EOM.keokalani'nui-9/26/2006
247Error. EOM.keokalani'nui-9/26/2006
246deCODE Files Suit to Defend Intellectual Property Tuesday September 26, 11:05 amnigel bates-9/26/2006
245deCODE Initiates Phase I Clinical Program for DG051 for the Prevention of Heart mopgcw-8/14/2006
244deCODE genetics Announces Second Quarter 2006 Financial Results Tuesday August 8mopgcw-8/8/2006
243Yeah. This makes me queasy. But what do ya do.keokalani'nui-7/14/2006
242deleted - tried to post today's chart and it didn't worktom pope-7/14/2006
241what a terrible time to come to market....mopgcw-7/14/2006
240deCODE to Raise $30 Million in Common Stock Offering Friday July 14, 9:27 am ET nigel bates-7/14/2006
239DCGN :Files IND for DG-051 for Prevention of Heart Attack 2006-07-05 02:46 (New mopgcw-7/12/2006
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News